These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35339512)

  • 1. Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19.
    Abraham GR; Kuc RE; Althage M; Greasley PJ; Ambery P; Maguire JJ; Wilkinson IB; Hoole SP; Cheriyan J; Davenport AP
    J Mol Cell Cardiol; 2022 Jun; 167():92-96. PubMed ID: 35339512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors.
    Willette RN; Sauermelch CF; Storer BL; Guiney S; Luengo JI; Xiang JN; Elliott JD; Ohlstein EH
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S149-57. PubMed ID: 9595425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotheliitis, endothelin, and endothelin receptor blockers in COVID-19.
    Sanghavi DK; Titus A; Caulfield TR; David Freeman W
    Med Hypotheses; 2021 May; 150():110564. PubMed ID: 33823371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19.
    Fisk M; Althage M; Moosmang S; Greasley PJ; Cope AP; Jayne DR; Galloway J; Hall F; Wilkinson IB; Ambery P; Cheriyan J
    Pulm Pharmacol Ther; 2021 Aug; 69():102035. PubMed ID: 33933611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors.
    Lipa JE; Neligan PC; Perreault TM; Baribeau J; Levine RH; Knowlton RJ; Pang CY
    Am J Physiol; 1999 Feb; 276(2):H359-67. PubMed ID: 9950834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade.
    Dashwood MR; Tsui JC
    Atherosclerosis; 2002 Feb; 160(2):297-304. PubMed ID: 11849651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced endothelin-1-induced contractions in mesenteric arteries from rats with congestive heart failure: role of ET(B) receptors.
    Bergdahl A; Valdemarsson S; Adner M; Sun XY; Hedner T; Edvinsson L
    Eur J Heart Fail; 2001 Jun; 3(3):293-9. PubMed ID: 11377999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
    Hay DW; Luttmann MA; Beck G; Ohlstein EH
    Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for vasoconstriction mediated by the endothelin-B receptor in domestic swine.
    Burke SE; Nelson RA; Lubbers NL; Ford TT; Fu KI; Padley RJ; Wegner CD; Cox BF
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):838-44. PubMed ID: 10836715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spasmogenic action of endothelin-1 on isolated equine pulmonary artery and bronchus.
    Benamou AE; Marlin DJ; Callingham BC; Hiley RC; Lekeux R
    Equine Vet J; 2003 Mar; 35(2):190-6. PubMed ID: 12638797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents.
    Ergul A
    Pharmacotherapy; 2002 Jan; 22(1):54-65. PubMed ID: 11794430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced endothelin-B-receptor-mediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia.
    Hasdai D; Mathew V; Schwartz RS; Smith LA; Holmes DR; Katusic ZS; Lerman A
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2737-43. PubMed ID: 9409250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro.
    Maguire JJ; Kuc RE; Davenport AP
    Br J Pharmacol; 2001 Nov; 134(6):1360-6. PubMed ID: 11704658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin and endothelin antagonists in hypertension.
    Schiffrin EL
    J Hypertens; 1998 Dec; 16(12 Pt 2):1891-5. PubMed ID: 9886874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs?
    Duru F; Barton M; Lüscher TF; Candinas R
    Cardiovasc Res; 2001 Feb; 49(2):272-80. PubMed ID: 11164837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1.
    Ruschitzka F; Shaw S; Gygi D; Noll G; Barton M; Lüscher TF
    J Am Soc Nephrol; 1999 May; 10(5):953-62. PubMed ID: 10232680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and perspective of endothelin-1 antagonism in acute heart failure.
    Kiowski W; Suetsch G; Oechslin E; Schalcher C; Brunner-Larocca HP; Bertel O
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S53-7. PubMed ID: 11811379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive inotropic responses mediated by endothelin ET(A) and ET(B) receptors in human myocardial trabeculae.
    Saetrum Opgaard O; Möller S; de Vries R; Edvinsson L; Saxena PR
    Clin Sci (Lond); 2000 Sep; 99(3):161-8. PubMed ID: 11787467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular actions of ET-B activation in vivo and modulation by receptor antagonism.
    Rasmussen TE; Jougasaki M; Supaporn T; Hallett JW; Brooks DP; Burnett JC
    Am J Physiol; 1998 Jan; 274(1):R131-8. PubMed ID: 9458909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.